Ijamsville, MD, United States of America

Norman E Ohler

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Other. Active years: 2012.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 92(Granted Patents)


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Norman E Ohler

Introduction

Norman E Ohler is a notable inventor based in Ijamsville, MD (US). He has made significant contributions to the field of chemistry, particularly in the development of chemical agents with potential therapeutic applications.

Latest Patents

Ohler holds a patent for "Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof." This patent describes chemical agents, such as disulfonamide derivatives, that act as anti-cancer and anti-tumor agents. These agents are particularly noteworthy for their ability to modulate the activity of the Wnt/β-catenin signaling pathway, which is crucial in cancer cell biology. The patent also outlines methods for preparing these agents, as well as pharmaceutical compositions containing them as active ingredients.

Career Highlights

Throughout his career, Norman E Ohler has focused on innovative solutions in the realm of chemical research. His work has the potential to impact cancer treatment significantly, showcasing his dedication to advancing medical science.

Collaborations

Ohler has collaborated with notable colleagues, including Wieslaw Marek Cholody and Yi Zang. These partnerships have likely contributed to the depth and breadth of his research endeavors.

Conclusion

Norman E Ohler's contributions to the field of chemistry, particularly in developing anti-cancer agents, highlight his innovative spirit and commitment to improving healthcare outcomes. His work continues to inspire advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…